A new software algorithm decides which patients are most likely to become infected with the virus. But this is not like other risk calculators, some experts say. Source: NYT > Business – Gina Kolata
Someday, an Arm Implant May Prevent H.I.V. Infection for a Year
In preliminary tests, a matchstick-size rod containing a new drug offered promise as a shield against the virus. But a large clinical trial must still be done. Source: NYT > Business – Donald G. McNeil Jr.
Global Health: Gilead Will Donate Truvada to U.S. for H.I.V. Prevention
The manufacturer will provide enough of the drug to supply 200,000 patients annually for more than a decade. Critics said it would not be enough to end the AIDS epidemic and questioned the company’s motives. Source: NYT > Business – DONALD G. McNEIL Jr.
Trump’s Proposed Budget Undermines His H.I.V. Plan, Experts Say
Strategies abound to end the AIDS epidemic, but expense — mostly for drugs costing up to $50,000 a year — is the inevitable obstacle. Source: NYT > Business – DONALD G. McNEIL Jr.